The invention is novel compounds having acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitory activity of the formula I
The invention further comprises a process for the preparation of compounds of the formula I, pharmaceutical compositions containing them and the use of compounds (I) for the preparation of pharmaceutical compositions useful for treating hypercholesterolemia and atherosklerosis.
本发明是具有式 I 的酰基辅酶 A:胆固醇酰基转移酶(ACAT)抑制活性的新型化合物。
本发明还包括制备式 I 化合物、含有这些化合物的药物组合物以及使用化合物 (I) 制备用于治疗高胆固醇血症和动脉粥样硬化症的药物组合物的工艺。
Triggering a [2]Rotaxane Molecular Shuttle by a Photochemical Bond-Cleavage Strategy
two stations in a [2]rotaxane is demonstrated by employing a photochemical bond-cleavage strategy. A photolabile bulk barrier is covalently introduced into two identical stations of the thread to prevent dynamic shuttling of the macrocycle, resulting in a “gated” state. Irradiation of UV light (λ = 365 nm) results in the complete removal of the bulk barrier and the balanced shuttling motion of the macrocycle